StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)

Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –

Elevance Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Elevance Health's operating income for the twelve months ending Sep 30, 2026 was $5.43B, down 28.2% year over year. For fiscal 2025 it was $7.20B, down 8.4% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $8.50B in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.20B-8.4%
FY2024Dec 31, 2024$7.86B-7.5%
FY2023Dec 31, 2023$8.50B+2.6%
FY2022Dec 31, 2022$8.28B+9.6%
FY2021Dec 31, 2021$7.56B+18.9%
FY2020Dec 31, 2020$6.36B+6.0%
FY2019Dec 31, 2019$6.00B+10.6%
FY2018Dec 31, 2018$5.43B+30.0%
FY2017Dec 31, 2017$4.18B-13.0%
FY2016Dec 31, 2016$4.80B+1.0%
FY2015Dec 31, 2015$4.75B+7.6%
FY2014Dec 31, 2014$4.42B+10.4%
FY2013Dec 31, 2013$4.00B+10.5%
FY2012Dec 31, 2012$3.62B-4.3%
FY2011Dec 31, 2011$3.78B-7.2%
FY2010Dec 31, 2010$4.08B-2.4%
FY2009Dec 31, 2009$4.18B-3.9%
FY2008Dec 31, 2008$4.35B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.27B-2.0%
Q2 FY2026Jun 30, 2026$1.76B-27.3%
Q1 FY2026Mar 31, 2026$2.09B-34.2%
Q4 FY2025Dec 31, 2025$309.00M-54.1%
Q3 FY2025Sep 30, 2025$1.30B-8.0%
Q2 FY2025Jun 30, 2025$2.43B-12.3%
Q1 FY2025Mar 31, 2025$3.17B+5.1%
Q4 FY2024Dec 31, 2024$673.00M-47.6%
Q3 FY2024Sep 30, 2024$1.41B-19.8%
Q2 FY2024Jun 30, 2024$2.77B+5.2%
Q1 FY2024Mar 31, 2024$3.02B+6.5%
Q4 FY2023Dec 31, 2023$1.28B+2.0%
Q3 FY2023Sep 30, 2023$1.76B-22.0%
Q2 FY2023Jun 30, 2023$2.63B+12.0%
Q1 FY2023Mar 31, 2023$2.83B+16.6%
Q4 FY2022Dec 31, 2022$1.26B+0.1%
Q3 FY2022Sep 30, 2022$2.25B+9.3%
Q2 FY2022Jun 30, 2022$2.35B+12.7%
Q1 FY2022Mar 31, 2022$2.43B+12.3%
Q4 FY2021Dec 31, 2021$1.26B+107.9%
Q3 FY2021Sep 30, 2021$2.06B+924.4%
Q2 FY2021Jun 30, 2021$2.08B-38.1%
Q1 FY2021Mar 31, 2021$2.16B-1.5%
Q4 FY2020Dec 31, 2020$605.00M-44.9%
Q3 FY2020Sep 30, 2020$201.00M-86.8%
Q2 FY2020Jun 30, 2020$3.36B+134.5%
Q1 FY2020Mar 31, 2020$2.19B+13.1%
Q4 FY2019Dec 31, 2019$1.10B+46.4%
Q3 FY2019Sep 30, 2019$1.53B+22.3%
Q2 FY2019Jun 30, 2019$1.43B-8.1%
Q1 FY2019Mar 31, 2019$1.94B+3.9%
Q4 FY2018Dec 31, 2018$750.00M+96.9%
Q3 FY2018Sep 30, 2018$1.25B+27.2%
Q2 FY2018Jun 30, 2018$1.56B+27.1%
Q1 FY2018Mar 31, 2018$1.87B+17.8%
Q4 FY2017Dec 31, 2017$381.00M-41.6%
Q3 FY2017Sep 30, 2017$982.00M–
Q2 FY2017Jun 30, 2017$1.23B–
Q1 FY2017Mar 31, 2017$1.59B–
Q4 FY2016Dec 31, 2016$652.30M–

More Elevance Health figures

See a number that looks wrong?